Lung Cancer Screening with Low-Dose Computed Tomography

Radiologic Clinics of North America

Volumn 52, Issue 1, 2014, Pages 27-46

  Chiles, Caroline ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Computed tomography; Lung cancer; Lung cancer screening; Pulmonary nodule; Thoracic imaging

Indexed keywords

AGE DISTRIBUTION; AGING; CANCER MORTALITY; CANCER SCREENING; CANCER SIZE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIFICATION; DIAGNOSTIC ERROR; FALSE POSITIVE RESULT; GROWTH RATE; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; INCIDENTAL FINDING; LOW DOSE COMPUTED TOMOGRAPHY; LUNG BIOPSY; LUNG CANCER; LUNG NODULE; MEDICAL HISTORY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SMOKING; SMOKING CESSATION; SOLID TUMOR; THORAX RADIOGRAPHY; TISSUE CHARACTERIZATION; TUMOR GROWTH;

COMPUTED TOMOGRAPHY; LUNG CANCER; LUNG CANCER SCREENING; PULMONARY NODULE; THORACIC IMAGING;

AGED; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; RADIATION DOSAGE; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84888194910     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2013.08.006     Document Type: Review

References (75)

1. Henschke C.I., McCauley D.I., Yankelevitz D.F., et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999, 354(9173):99-105.
2. Kaneko M., Eguchi K., Ohmatsu H., et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996, 201(3):798-802.
3. Sone S., Takashima S., Li F., et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998, 351(9111):1242-1245.
4. Nawa T., Nakagawa T., Kusano S., et al. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 2002, 122(1):15-20.
5. Thun M.J., Carter B.D., Feskanich D., et al. 50-year trends in smoking-related mortality in the United States. NEngl J Med 2013, 368(4):351-364.
6. 2013. Available at:. Accessed July 15, 2013. http://seer.cancer.gov/csr/1975_2010/results_merged/sect_15_lung_bronchus.pdf.
7. Henschke C.I., Naidich D.P., Yankelevitz D.F., et al. Early lung cancer action project: initial findings on repeat screenings. Cancer 2001, 92(1):153-159.
8. Sone S., Li F., Yang Z.G., et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001, 84(1):25-32.
9. Swensen S.J., Jett J.R., Hartman T.E., et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003, 226(3):756-761.
10. National Lung Screening Trial Research Team, Aberle D.R., Adams A.M., Berg C.D., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. NEngl J Med 2011, 365(5):395-409.
11. National Lung Screening Trial Research Team, Aberle D.R., Adams A.M., Berg C.D., et al. Baseline characteristics of participants in the randomized national lung screening trial. JNatl Cancer Inst 2010, 102(23):1771-1779.
12. Oken M.M., Hocking W.G., Kvale P.A., et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011, 306(17):1865-1873.
13. Jaklitsch M.T., Jacobson F.L., Austin J.H., et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. JThorac Cardiovasc Surg 2012, 144(1):33-38.
14. Wender R., Fontham E.T., Barrera E., et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013, 63(2):106-117.
15. Wood D.E., Eapen G.A., Ettinger D.S., et al. Lung cancer screening. JNatl Compr Canc Netw 2012, 10(2):240-265.
16. Bach P.B., Mirkin J.N., Oliver T.K., et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012, 307(22):2418-2429.
17. Ma J., Ward E.M., Smith R., et al. Annual number of lungcancer deaths potentially avertable by screening in the United States. Cancer 2013, 119(7):1381-1385.
18. Pinsky P.F., Berg C.D. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?. JMed Screen 2012, 19(3):154-156.
19. International Early Lung Cancer Action Program Investigators, Henschke C.I., Yankelevitz D.F., Libby D.M., et al. Survival of patients with stage I lung cancer detected on CT screening. NEngl J Med 2006, 355(17):1763-1771.
20. Bach P.B., Kattan M.W., Thornquist M.D., et al. Variations in lung cancer risk among smokers. JNatl Cancer Inst 2003, 95(6):470-478.
21. Spitz M.R., Hong W.K., Amos C.I., et al. Arisk model for prediction of lung cancer. JNatl Cancer Inst 2007, 99(9):715-726.
22. Cassidy A., Myles J.P., van Tongeren M., et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008, 98(2):270-276.
23. Etzel C.J., Bach P.B. Estimating individual risk for lung cancer. Semin Respir Crit Care Med 2011, 32(1):3-9.
24. D'Amelio A.M., Cassidy A., Asomaning K., et al. Comparison of discriminatory power and accuracy of three lung cancer risk models. Br J Cancer 2010, 103(3):423-429.
25. Tammemagi M.C., Katki H.A., Hocking W.G., et al. Selection criteria for lung-cancer screening. NEngl J Med 2013, 368(8):728-736.
26. National Lung Screening Trial Research Team, Aberle D.R., Berg C.D., Black W.C., et al. The National Lung Screening Trial: overview and study design. Radiology 2011, 258(1):243-253.
27. Larke F.J., Kruger R.L., Cagnon C.H., et al. Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial. AJR Am J Roentgenol 2011, 197(5):1165-1169.
28. Mascalchi M., Mazzoni L.N., Falchini M., et al. Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT. Br J Radiol 2012, 85(1016):1134-1139.
29. Xu D.M., Gietema H., de Koning H., et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006, 54(2):177-184.
30. de Hoop B., Gietema H., van de Vorst S., et al. Pulmonary ground-glass nodules: increase in mass as an early indicator of growth1. Radiology 2010, 255(1):199-206.
31. Manowitz A., Sedlar M., Griffon M., et al. Use of BMI guidelines and individual dose tracking to minimize radiation exposure from low-dose helical chest CT scanning in a lung cancer screening program. Acad Radiol 2012, 19(1):84-88.
32. Funama Y., Awai K., Liu D., et al. Detection of nodules showing ground-glass opacity in the lungs at low-dose multidetector computed tomography: phantom and clinical study. JComput Assist Tomogr 2009, 33(1):49-53.
33. MacMahon H., Austin J.H., Gamsu G., et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005, 237(2):395-400.
34. Good C.A., Wilson T.W. The solitary circumscribed pulmonary nodule; study of seven hundred five cases encountered roentgenologically in a period of three and one-half years. JAm Med Assoc 1958, 166(3):210-215.
35. Diederich S., Wormanns D., Semik M., et al. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002, 222(3):773-781.
36. Ahn M.I., Gleeson T.G., Chan I.H., et al. Perifissural nodules seen at CT screening for lung cancer. Radiology 2010, 254(3):949-956.
37. de Hoop B., van Ginneken B., Gietema H., et al. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy. Radiology 2012, 265(2):611-616.
38. Takashima S., Sone S., Li F., et al. Small solitary pulmonary nodules (< or=1 cm) detected at population-based CT screening for lung cancer: reliable high-resolution CT features of benign lesions. AJR Am J Roentgenol 2003, 180(4):955-964.
39. Slattery M.M., Foley C., Kenny D., et al. Long-term follow-up of non-calcified pulmonary nodules (<10 mm) identified during low-dose CT screening for lung cancer. Eur Radiol 2012, 22(9):1923-1928.
40. Henschke C.I., Yankelevitz D.F., Mirtcheva R., et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002, 178(5):1053-1057.
41. Li F., Sone S., Abe H., et al. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology 2004, 233(3):793-798.
42. Lee S.M., Park C.M., Goo J.M., et al. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features. Radiology 2013, 268(1):265-273.
43. Travis W.D., Brambilla E., Noguchi M., et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. JThorac Oncol 2011, 6(2):244-285.
44. Ko J.P., Berman E.J., Kaur M., et al. Pulmonary Nodules: growth rate assessment in patients by using serial CT and three-dimensional volumetry. Radiology 2012, 262(2):662-671.
45. Henschke C.I., Yankelevitz D.F., Yip R., et al. Lung cancers diagnosed at annual CT screening: volume doubling times. Radiology 2012, 263(2):578-583.
46. Heuvelmans M.A., Oudkerk M., de Bock G.H., et al. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Eur Radiol 2013, 23(7):1836-1845.
47. Kakinuma R., Ashizawa K., Kuriyama K., et al. Measurement of focal ground-glass opacity diameters on CT images: interobserver agreement in regard to identifying increases in the size of ground-glass opacities. Acad Radiol 2012, 19(4):389-394.
48. Hasegawa M., Sone S., Takashima S., et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000, 73(876):1252-1259.
49. Takahashi S., Tanaka N., Okimoto T., et al. Long term follow-up for small pure ground-glass nodules: implications of determining an optimum follow-up period and high-resolution CT findings to predict the growth of nodules. Jpn J Radiol 2012, 30(3):206-217.
50. Godoy M.C., Naidich D.P. Overview and strategic management of subsolid pulmonary nodules. JThorac Imaging 2012, 27(4):240-248.
51. Godoy M.C., Sabloff B., Naidich D.P. Subsolid pulmonary nodules: imaging evaluation and strategic management. Curr Opin Pulm Med 2012, 18(4):304-312.
52. Soriano J.B., Zielinski J., Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009, 374(9691):721-732.
53. Tammemagi C.M., Pinsky P.F., Caporaso N.E., et al. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. JNatl Cancer Inst 2011, 103(13):1058-1068.
54. Mets O.M., Buckens C.F., Zanen P., et al. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. JAMA 2011, 306(16):1775-1781.
55. Smith B.M., Pinto L., Ezer N., Sverzellati N., et al. Emphysema detected on computed tomography and risk of lung cancer: a systematic review and meta-analysis. Lung Cancer 2012, 77(1):58-63.
56. Jacobs P.C., Gondrie M.J., van der Graaf Y., et al. Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer. AJR Am J Roentgenol 2012, 198(3):505-511.
57. McEvoy J.W., Blaha M.J., Rivera J.J., et al. Mortality rates in smokers and nonsmokers in the presence or absence of coronary artery calcification. JACC Cardiovasc Imaging 2012, 5(10):1037-1045.
58. Shemesh J., Henschke C.I., Shaham D., et al. Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease. Radiology 2010, 257(2):541-548.
59. Priola A.M., Priola S.M., Giaj-Levra M., et al. Clinical implications and added costs of incidental findings in an early detection study of lung cancer by using low-dose spiral computed tomography. Clin Lung Cancer 2013, 14(2):139-148.
60. van de Wiel J.C., Wang Y., Xu D.M., et al. Neglectable benefit of searching for incidental findings in the Dutch-Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT. Eur Radiol 2007, 17(6):1474-1482.
61. Rampinelli C., Preda L., Maniglio M., et al. Extrapulmonary malignancies detected at lung cancer screening. Radiology 2011, 261(1):293-299.
62. McKee B.J., McKee A.B., Flacke S., et al. Initial experience with a free, high-volume, low-dose CT lung cancer screening program. JAm Coll Radiol 2013, 10(8):586-592.
63. Jonnalagadda S., Bergamo C., Lin J.J., et al. Beliefs and attitudes about lung cancer screening among smokers. Lung Cancer 2012, 77(3):526-531.
64. Brenner D.J. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 2004, 231(2):440-445.
65. Brenner D.J., Hall E.J. Computed tomography-an increasing source of radiation exposure. NEngl J Med 2007, 357(22):2277-2284.
66. Mettler F.A., Huda W., Yoshizumi T.T., et al. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008, 248(1):254-263.
67. Hendrick R.E. Radiation doses and cancer risks from breast imaging studies. Radiology 2010, 257(1):246-253.
68. Shuryak I., Sachs R.K., Brenner D.J. Cancer risks after radiation exposure in middle age. JNatl Cancer Inst 2010, 102(21):1628-1636.
69. Bleyer A., Welch H.G. Effect of three decades of screening mammography on breast-cancer incidence. NEngl J Med 2012, 367(21):1998-2005.
70. Veronesi G., Maisonneuve P., Bellomi M., et al. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2012, 157(11):776-784.
71. Henschke C.I., Yankelevitz D.F., Yip R., et al. Lung cancers diagnosed at annual CT screening: volume doubling times. Radiology 2012, 263(2):578-583.
72. Hazelton W.D., Goodman G., Rom W.N., et al. Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers. Math Biosci 2012, 240(1):20-34.
73. van der Aalst C.M., van Klaveren R.J., van den Bergh K.A., et al. The impact of a lung cancer computed tomography screening result on smoking abstinence. Eur Respir J 2011, 37(6):1466-1473.
74. Ashraf H., Tonnesen P., Holst Pedersen J., et al. Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax 2009, 64(5):388-392.
75. Barry S.A., Tammemagi M.C., Penek S., et al. Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. JNatl Cancer Inst 2012, 104(21):1647-1659.